Effects of Boswellia serrata gum resin in patients with osteoarthritis of knee

Key finding

8-week crossover RCT (n=30) found Boswellia serrata extract significantly reduced knee pain, increased flexion, and improved walking distance in osteoarthritis vs placebo.

Critique

Widely cited as evidence that boswellia works for knee osteoarthritis, but the trial has substantial methodological limitations. n=30 in a crossover design means each condition was observed in effectively 15 patients at a time, which is underpowered for the reported effect magnitude. 8 weeks total is short for osteoarthritis symptom trajectories. Outcomes were subjective, there was no active comparator, and the study was single-center. Later boswellia trials have used different extract forms (5-LOXIN, Aflapin) at different doses, so there is no direct replication of the specific intervention tested here.

What would be more convincing

An 800-patient multi-center RCT comparing a standardized boswellia serrata extract at a fixed dose against an active comparator (e.g., celecoxib or ibuprofen) with 12-week duration and WOMAC as the primary outcome would move boswellia from 'plausibly useful for OA' to 'evidence-supported.'

Reviewed 2026-04-21 · Opinion based on verifiable facts in the published paper.